المؤلفون: А. S. Petrikov, Т. V. Vavilova, А. V. Vardanyan, М. N. Zamyatin, I. А. Zolotukhin, К. V. Lobastov, Е. V. Roitman, Е. I. Seliverstov, Yu. М. Stoyko, I. А. Suchkov

المصدر: Фармакоэкономика, Vol 17, Iss 2, Pp 251-278 (2024)

مصطلحات موضوعية: venous thromboembolism, vte, caprini score, primary prevention of venous thrombosis, low molecular weight heparins, lmwh, anti-xa activity, body weight, body mass index, bmi, efficacy, safety, Therapeutics. Pharmacology, RM1-950, Economics as a science, HB71-74

وصف الملف: electronic resource

Relation: https://www.pharmacoeconomics.ru/jour/article/view/1015; https://doaj.org/toc/2070-4909; https://doaj.org/toc/2070-4933

URL الوصول: https://doaj.org/article/af03c899590b433e988626bb5f97aac4